To the full analysis
Chemours stock: growth
CCChemours reported $5.81B in revenue for fiscal 2025, up 0.4% on the prior year, up 3.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−2.2%
per year from 2011 to 2025, per share −0.9%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−19.9%
per year from 2011 to 2025, per share −18.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2011 | |
|---|---|---|---|
| Revenue | 3.2% | 0.2% | −2.2% |
| Revenue per share | 5.1% | 2.0% | −0.9% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −37.6% | no data | −19.9% |
| Free cash flow per share | −36.5% | no data | −18.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2011 | $7.97B | $1.43B | $1.14B |
| 2012 | $7.37B | $1.06B | $958M |
| 2013 | $6.86B | $423M | $360M |
| 2014 | $6.43B | $400M | −$99M |
| 2015 | $5.72B | −$90M | −$337M |
| 2016 | $5.4B | $7M | $256M |
| 2017 | $6.18B | $746M | $228M |
| 2018 | $6.64B | $995M | $642M |
| 2019 | $5.53B | −$52M | $169M |
| 2020 | $4.97B | $219M | $540M |
| 2021 | $6.35B | $608M | $537M |
| 2022 | $6.83B | $578M | $448M |
| 2023 | $6.08B | −$238M | $186M |
| 2024 | $5.78B | $86M | −$993M |
| 2025 | $5.81B | −$386M | $51M |
Revenue by segment
How The Chemours Company makes its money and how that has shifted. Names are as the company reports them.
- Titanium Technologies42%
- Thermal And Specialized Solutions36%
- Advanced Performance Materials22%
- Other< 1%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|
| Titanium Technologies | $2.4B | $3.36B | $3.38B | $2.68B | $2.57B | $2.43B | 41.8% |
| Thermal And Specialized Solutions | $1.11B | $1.26B | $1.68B | $1.82B | $1.83B | $2.07B | 35.6% |
| Advanced Performance Materials | $1.1B | $1.4B | $1.62B | $1.44B | $1.33B | $1.26B | 21.7% |
| Other | $358M | $336M | $153M | $136M | $0 | $0 | 0% |
| Total revenue | $4.97B | $6.35B | $6.83B | $6.08B | $5.78B | $5.81B | 100% |
Revenue by region
Where The Chemours Company generates its revenue.
- North America46%
- Asia Pacific21%
- EMEA20%
- Latin America13%
Figures as a table
| 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|
| North America | $2.7B | $2.59B | $2.65B | 45.7% |
| Asia Pacific | $1.46B | $1.39B | $1.24B | 21.4% |
| EMEA | $1.19B | $1.14B | $1.16B | 20% |
| Latin America | $674M | $669M | $748M | 12.9% |
| Total revenue | $6.08B | $5.78B | $5.81B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 20 Feb 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.